PEPTONIC medical ABXSAT:PMED Days Payable is 305.11 as of Mar. 2026, which is 94% above its 10-year median of 157.44. The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, PEPTONIC medical AB ranks better than 94.58% on this metric.
The historical rank and industry rank for PEPTONIC medical AB's Days Payable or its related term are showing as below:
XSAT:PMED'
s Days Payable Range Over the Past 10 Years
Min: 93.77 Med: 157.44 Max: 2767.72
Current: 461.44
During the past 13 years, PEPTONIC medical AB's highest Days Payable was 2767.72. The lowest was 93.77. And the median was 157.44.
XSAT:PMED's Days Payable is ranked better than 94.58% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.61
vs XSAT:PMED: 461.44
PEPTONIC medical AB's Days Payable
increased
from Mar. 2025 (287.50) to Mar. 2026 (305.11).
It may suggest that PEPTONIC medical ABdelayed paying its suppliers.
PEPTONIC medical AB Days Payable Related Terms
PEPTONIC medical AB Days Payable Historical Data
* Premium members only.
The historical data trend for PEPTONIC medical AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:PMED vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PEPTONIC medical AB Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's Days Payable distribution charts can be found below:
* The bar in red indicates where PEPTONIC medical AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PEPTONIC medical AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PEPTONIC medical AB (XSAT:PMED) has a Days Payable of 305.11 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PEPTONIC medical AB and its competitors. This is 94% above median its historical median of 157.44. Over the past decade, PEPTONIC medical AB's Days Payable has ranged from 93.77 to 2,767.72. According to the industry distribution chart, PEPTONIC medical AB ranks #50 out of 922 companies in the Drug Manufacturers industry, placing it in the top 5.4%.
Is PEPTONIC medical AB's Days Payable too high?
PEPTONIC medical AB's current Days Payable of 305.11 is 94% above median its 10-year median of 157.44. Over the past 10 years, this metric has ranged from a low of 93.77 to a high of 2,767.72. The Drug Manufacturers industry median Days Payable is 90.61. PEPTONIC medical AB's value of 305.11 is 236.7% above this industry median. Based on the distribution chart, PEPTONIC medical AB ranks #50 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does PEPTONIC medical AB's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PEPTONIC medical AB ranks #50 out of 922 companies for Days Payable. This places PEPTONIC medical AB in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.61. PEPTONIC medical AB's value of 305.11 is 236.7% above this benchmark. Historically, PEPTONIC medical AB's own Days Payable has ranged from 93.77 to 2,767.72 over the past decade. While the company's 10-year median is 157.44 vs. the industry median of 90.61, PEPTONIC medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PEPTONIC medical AB's current Days Payable of 305.11 is 236.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PEPTONIC medical AB and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PEPTONIC medical AB's current Days Payable is 305.11, which is 94% above median its own 10-year median of 157.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PEPTONIC medical AB stock overvalued right now?
PEPTONIC medical AB (XSAT:PMED) has a current Days Payable of 305.11. The current Days Payable is 305.11, which is 94% above median its 10-year median of 157.44 and 236.7% above the Drug Manufacturers industry median of 90.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PEPTONIC medical AB (XSAT:PMED), the current Days Payable is 305.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:PMED has been successfully added to your 